Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue
+4.59%
EPS
+128.9%
Free cash flow
−9.03%
Total debt
−4.51%

Quarter to September 2026, against a year earlier

15.14 0.51 −3.26%
Market cap
$10.3B
P/E
30.3×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 30.10
P/S ratio
1.19 0.81 1.02 1.54
P/FCF ratio
15.76 12.07 14.72 23.20
P/Operating CF
51.08 90.25 37.57 52.23
P/B ratio
1.40 0.95 1.19 1.75
EV/Sales
1.74 1.35 1.54 2.02
EV/EBITDA
65.97 68.22 80.81 14.68
EV/FCF
22.99 20.13 22.18 30.53
Current Ratio
1.78 1.76 1.78 1.89
Net Debt/EBITDA
15.46 17.14 14.80 13.06
Debt/Equity
0.71 0.68 0.66 0.63
Earnings Yield
(6.81%) (10.33%) (8.48%) 3.32%
Free Cash Flow Yield
6.35% 8.29% 6.79% 4.31%
Free Cash Flow per Share
0.17 0.04 0.21 0.23
Book value per Share
8.18 8.27 8.33 8.62
Free Cash Flow
117.20 25.20 140.60 156.20
EV/EBIT
0.00 0.00 0.00 27.52
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026